Biora Therapeutics Inc

Biora Therapeutics, Inc. is a clinical-stage biotechnology company that develops oral biotherapeutics in the United States. Its platforms include NaviCap, a targeted oral delivery system for gastrointestinal therapeutics aimed at improving treatment of inflammatory bowel diseases, and BioJet, a systemic oral delivery platform designed to replace injections with needle-free oral delivery of large molecules for chronic disease management. The company was formerly known as Progenity, Inc. and changed its name to Biora Therapeutics, Inc. in April 2022 to reflect its focus on its therapeutics pipeline. Founded in 2010 and headquartered in San Diego, California, the company filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware on December 27, 2024.